Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2009-09-09

FDA Approved: LANTUS SOLOSTAR — Supplemental Application (sanofi-aventis U.S. LLC)

View source ↗

Summary

The FDA approved a supplemental application for Lantus SoloStar (insulin glargine) from Sanofi‑Aventis U.S. LLC, indicating an update to the product's labeling/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lantus SoloStar (Insulin glargine)

Snippet

SUPPL AP for LANTUS SOLOSTAR (INSULIN GLARGINE)